Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 319

1.

Necrotizing enterocolitis after intravitreal bevacizumab in an infant with Incontinentia Pigmenti - a case report.

Kunzmann S, Ngyuen T, Stahl A, Walz JM, Nentwich MM, Speer CP, Ruf K.

BMC Pediatr. 2019 Oct 15;19(1):353. doi: 10.1186/s12887-019-1732-z.

2.

MHCquant: Automated and reproducible data analysis for immunopeptidomics.

Bichmann L, Nelde A, Ghosh M, Heumos L, Mohr C, Peltzer A, Kuchenbecker L, Sachsenberg T, Walz JS, Stevanović S, Rammensee HG, Kohlbacher O.

J Proteome Res. 2019 Oct 7. doi: 10.1021/acs.jproteome.9b00313. [Epub ahead of print]

PMID:
31589052
3.

Comparison between Zumsteg classification and Briganti nomogram for the risk of lymph-node invasion before radical prostatectomy.

Branger N, Pignot G, Lannes F, Koskas Y, Toledano H, Thomassin-Piana J, Giusiano S, Alessandrini M, Rossi D, Walz J, Bastide C.

World J Urol. 2019 Sep 27. doi: 10.1007/s00345-019-02965-7. [Epub ahead of print]

PMID:
31560121
4.

Reply by Authors.

Farolfi A, Gafita A, Calais J, Eiber M, Afshar-Oromieh A, Spohn F, Barbato F, Weber M, Ilhan H, Cervati V, Wetter A, Hadaschik B, Briganti A, Walz J, Pianori D, Fanti S, Haberkorn U, Herrmann K, Fendler WP.

J Urol. 2019 Sep 16:10109701JU00005826808699812. doi: 10.1097/01.JU.0000582680.86998.12. [Epub ahead of print] No abstract available.

PMID:
31524577
5.

"Real-world" evaluation of 18F-Choline PET/CT practices in prostate cancer patients and impact on changes in therapeutic strategy.

Niziers V, Boissier R, Borchiellini D, Deville JL, Khoury C, Durand M, Toledano H, Albert T, Branger N, Bandelier Q, Ouvrier MJ, Gabriel S, Hoch B, Gross E, Walz J, Brenot-Rossi I, Pignot G.

Urol Oncol. 2019 Aug 22. pii: S1078-1439(19)30294-7. doi: 10.1016/j.urolonc.2019.07.017. [Epub ahead of print]

PMID:
31447087
6.

The role of autologous stem cell transplantation in peripheral T cell lymphoma: a long-term follow-up single-center experience.

Roerden M, Walz JS, Müller MR, Sökler M, Federmann B, Kanz L, Bethge W, Vogel W.

J Cancer Res Clin Oncol. 2019 Oct;145(10):2595-2604. doi: 10.1007/s00432-019-02999-9. Epub 2019 Aug 13.

PMID:
31410605
7.

RE: Preventability of hospital onset bacterermia and fungemia: A pilot study of potential healthcare-associated infection outcome measure, by Dantes et al (2019).

Civitarese AM, Ruggieri E, Walz JM, Mack DA, Heard SO, Mitchell M, Lilly CM, Landry KE, Ellison RT.

Infect Control Hosp Epidemiol. 2019 Oct;40(10):1209-1210. doi: 10.1017/ice.2019.193. Epub 2019 Jul 25. No abstract available.

PMID:
31340877
8.

Let's Keep It at One Step at a Time: Why Biparametric Magnetic Resonance Imaging Is Not the Priority Today.

Walz J.

Eur Urol. 2019 Jul 11. pii: S0302-2838(19)30518-4. doi: 10.1016/j.eururo.2019.06.028. [Epub ahead of print] No abstract available.

PMID:
31303257
9.

Opioid Use and Respiratory Compromise in the Interventional Suite: A Wake-up Call.

Rosen MP, Walz JM.

Radiology. 2019 Sep;292(3):711-712. doi: 10.1148/radiol.2019191173. Epub 2019 Jul 2. No abstract available.

PMID:
31268838
10.

68Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study.

Farolfi A, Gafita A, Calais J, Eiber M, Afshar-Oromieh A, Spohn F, Barbato F, Weber M, Ilhan H, Cervati V, Wetter A, Hadaschik B, Briganti A, Walz J, Pianori D, Fanti S, Haberkorn U, Herrmann K, Fendler WP.

J Urol. 2019 Jun 24:101097JU0000000000000417. doi: 10.1097/JU.0000000000000417. [Epub ahead of print]

PMID:
31233369
11.

[Is a routine second transurethral resection of the bladder still necessary after hexaminolévulinate photodynamic diagnosis-assisted TURBT?]

Doisy L, Walz J, Fakhfakh S, Rybikowski S, Koskas Y, Gravis G, Pignot G.

Prog Urol. 2019 May - Jun;29(6):332-339. doi: 10.1016/j.purol.2019.04.001. Epub 2019 May 16. French.

PMID:
31104952
12.

Rely on Your Eyes or on Your Mind? How Magnetic Resonance Imaging Before First Biopsy Could Become Feasible.

Walz J.

Eur Urol Oncol. 2018 Jun;1(2):118-119. doi: 10.1016/j.euo.2018.04.007. Epub 2018 May 15. No abstract available.

PMID:
31100234
13.

Extent of positive surgical margins following radical prostatectomy: impact on biochemical recurrence with long-term follow-up.

Koskas Y, Lannes F, Branger N, Giusiano S, Guibert N, Pignot G, Walz J, Rossi D, Bastide C.

BMC Urol. 2019 May 15;19(1):37. doi: 10.1186/s12894-019-0470-8.

14.

Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments.

Farolfi A, Fendler W, Iravani A, Haberkorn U, Hicks R, Herrmann K, Walz J, Fanti S.

Eur Urol Oncol. 2019 Mar;2(2):152-162. doi: 10.1016/j.euo.2019.01.001. Epub 2019 Jan 31. Review.

PMID:
31017091
15.

Cytology and the cell block method in diagnostic characterization of canine lymphadenopathy and in the immunophenotyping of nodal lymphoma.

Heinrich DA, Avery AC, Henson MS, Overmann JA, Rendahl AK, Walz JZ, Seelig DM.

Vet Comp Oncol. 2019 Sep;17(3):365-375. doi: 10.1111/vco.12484. Epub 2019 Jun 13.

PMID:
31012996
16.

A Systematic Review on the Role of Imaging in Early Recurrent Prostate Cancer.

De Visschere PJL, Standaert C, Fütterer JJ, Villeirs GM, Panebianco V, Walz J, Maurer T, Hadaschik BA, Lecouvet FE, Giannarini G, Fanti S.

Eur Urol Oncol. 2019 Feb;2(1):47-76. doi: 10.1016/j.euo.2018.09.010. Epub 2018 Oct 24. Review.

PMID:
30929846
17.

Antigen Targets for the Development of Immunotherapies in Leukemia.

Bauer J, Nelde A, Bilich T, Walz JS.

Int J Mol Sci. 2019 Mar 20;20(6). pii: E1397. doi: 10.3390/ijms20061397. Review.

18.

Early hMSC morphology and proliferation on model polyelectrolyte multilayers.

Ding I, Walz JA, Mace CR, Peterson AM.

Colloids Surf B Biointerfaces. 2019 Jun 1;178:276-284. doi: 10.1016/j.colsurfb.2019.02.055. Epub 2019 Feb 28.

PMID:
30878802
19.

Adjunctive tianeptine treatment for bipolar disorder: A 24-week randomized, placebo-controlled, maintenance trial.

Kauer-Sant'Anna M, Frey BN, Fijtman A, Loredo-Souza AC, Dargél AA, Pfaffenseller B, Wollenhaupt-Aguiar B, Gazalle FK, Colpo GD, Passos IC, Bücker J, Walz JC, Jansen K, Ceresér KM, Bürke Bridi KP, Dos Santos Sória L, Kunz M, Pinho M, Kapczinski NS, Goi PD, Magalhães PV, Reckziegel R, Burque RK, de Azevedo Cardoso T, Kapczinski F.

J Psychopharmacol. 2019 Apr;33(4):502-510. doi: 10.1177/0269881119826602. Epub 2019 Mar 5.

PMID:
30835152
20.

Measurement of Ultralow Heating Rates of a Single Antiproton in a Cryogenic Penning Trap.

Borchert MJ, Blessing PE, Devlin JA, Harrington JA, Higuchi T, Morgner J, Smorra C, Wursten E, Bohman M, Wiesinger M, Mooser A, Blaum K, Matsuda Y, Ospelkaus C, Quint W, Walz J, Yamazaki Y, Ulmer S.

Phys Rev Lett. 2019 Feb 1;122(4):043201. doi: 10.1103/PhysRevLett.122.043201.

PMID:
30768304
21.

Complications, oncological and functional outcomes of salvage treatment options following focal therapy for localized prostate cancer: a systematic review and a comprehensive narrative review.

Marra G, Gontero P, Walz JC, Sivaraman A, Tourinho-Barbosa R, Cathelineau X, Sanchez-Salas R.

World J Urol. 2019 Aug;37(8):1517-1534. doi: 10.1007/s00345-019-02642-9. Epub 2019 Feb 1.

PMID:
30710157
22.

Impact of angiogenic activation and inhibition on miRNA profiles of human retinal endothelial cells.

Walz JM, Wecker T, Zhang PP, Cakir B, Gruening B, Agostini H, Reuer T, Ludwig F, Boneva S, Faerber L, Lange C, Schlunck GR, Stahl A.

Exp Eye Res. 2019 Apr;181:98-104. doi: 10.1016/j.exer.2019.01.006. Epub 2019 Jan 4.

23.

Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin.

Kuželová K, Brodská B, Schetelig J, Röllig C, Ráčil Z, Walz JS, Helbig G, Fuchs O, Vraná M, Pecherková P, Šálek C, Mayer J.

PLoS One. 2018 Dec 17;13(12):e0204290. doi: 10.1371/journal.pone.0204290. eCollection 2018.

24.

The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy.

Bilich T, Nelde A, Bichmann L, Roerden M, Salih HR, Kowalewski DJ, Schuster H, Tsou CC, Marcu A, Neidert MC, Lübke M, Rieth J, Schemionek M, Brümmendorf TH, Vucinic V, Niederwieser D, Bauer J, Märklin M, Peper JK, Klein R, Kohlbacher O, Kanz L, Rammensee HG, Stevanović S, Walz JS.

Blood. 2019 Feb 7;133(6):550-565. doi: 10.1182/blood-2018-07-866830. Epub 2018 Dec 10.

PMID:
30530751
25.

Consensus on molecular imaging and theranostics in prostate cancer.

Fanti S, Minozzi S, Antoch G, Banks I, Briganti A, Carrio I, Chiti A, Clarke N, Eiber M, De Bono J, Fizazi K, Gillessen S, Gledhill S, Haberkorn U, Herrmann K, Hicks RJ, Lecouvet F, Montironi R, Ost P, O'Sullivan JM, Padhani AR, Schalken JA, Scher HI, Tombal B, van Moorselaar RJA, Van Poppel H, Vargas HA, Walz J, Weber WA, Wester HJ, Oyen WJG.

Lancet Oncol. 2018 Dec;19(12):e696-e708. doi: 10.1016/S1470-2045(18)30604-1.

PMID:
30507436
26.

Parental views on the principles for cluster randomised trials involving neonates and infants.

Thiele N, Walz JM, Lindacher V, Mader S, Greisen G; EFCNI Parents Advisory Board.

Acta Paediatr. 2019 May;108(5):789-791. doi: 10.1111/apa.14664. Epub 2018 Dec 14. No abstract available.

PMID:
30475419
27.

Historical perspectives on contemporary human-environment dynamics in southeast Africa.

Douglass K, Walz J, Quintana Morales E, Marcus R, Myers G, Pollini J.

Conserv Biol. 2019 Apr;33(2):260-274. doi: 10.1111/cobi.13244. Epub 2019 Jan 28. Review.

PMID:
30411404
28.

Semaphorin 3F Modulates Corneal Lymphangiogenesis and Promotes Corneal Graft Survival.

Reuer T, Schneider AC, Cakir B, Bühler AD, Walz JM, Lapp T, Lange C, Agostini H, Schlunck G, Cursiefen C, Reinhard T, Bock F, Stahl A.

Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):5277-5284. doi: 10.1167/iovs.18-24287.

PMID:
30383199
29.

What Needs To Be Done Before Prostate Magnetic Resonance Imaging Can Safely Be Applied in the General Population.

Walz J.

Eur Urol. 2019 Mar;75(3):397-398. doi: 10.1016/j.eururo.2018.10.020. Epub 2018 Oct 28. No abstract available.

PMID:
30377008
30.

Unexpected response to cisplatin rechallenge after immune checkpoint inhibitors in patients with metastatic urothelial carcinoma refractory to platinum regimen.

Gravis G, Billon E, Baldini C, Massard C, Hilgers W, Delva R, Walz J, Pignot G, Rybikowski S, Dermeche S, Thomassin J, Brunelle S, Lavaud P, Loriot Y; French Genito-Urinary Tumor Group (GETUG).

Eur J Cancer. 2018 Nov;104:236-238. doi: 10.1016/j.ejca.2018.09.002. Epub 2018 Oct 11. No abstract available.

PMID:
30316610
31.

Spontaneous brain network activity: Analysis of its temporal complexity.

Pedersen M, Omidvarnia A, Walz JM, Zalesky A, Jackson GD.

Netw Neurosci. 2017 Jun 1;1(2):100-115. doi: 10.1162/NETN_a_00006. eCollection 2017 Spring.

32.

Focal Therapy for Prostate Cancer: A More Vehement View of the Approach Could Translate into Real Benefits for Our Patients.

Sanchez-Salas R, de la Rosette J, Polascik TJ, Carneiro A, Sivaraman A, Cathelineau X, Walz J.

Eur Urol. 2018 Nov;74(5):537-539. doi: 10.1016/j.eururo.2018.04.018. Epub 2018 May 1.

PMID:
29724502
33.

Correlation of Cell Surface Biomarker Expression Levels with Adhesion Contact Angle Measured by Lateral Microscopy.

Walz JA, Mace CR.

Anal Chem. 2018 Jun 5;90(11):6572-6579. doi: 10.1021/acs.analchem.8b00268. Epub 2018 May 8.

PMID:
29712419
34.

Re: Surveillance or Metastasis-directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial.

Walz J.

Eur Urol. 2018 Aug;74(2):235-236. doi: 10.1016/j.eururo.2018.03.037. Epub 2018 Apr 19. No abstract available.

PMID:
29680732
35.

[Treated cases of retinopathy of prematurity in Germany : 5-year data from the Retina.net ROP registry].

Walz JM, Bemme S, Reichl S, Akman S, Breuß H, Süsskind D, Glitz B, Müller VC, Wagenfeld L, Gabel-Pfisterer A, Aisenbrey S, Engelmann K, Koutsonas A, Krohne TU, Stahl A; Retina.net ROP-Register-Studiengruppe.

Ophthalmologe. 2018 Jun;115(6):476-488. doi: 10.1007/s00347-018-0701-5. German.

PMID:
29637302
36.

HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy.

Nelde A, Kowalewski DJ, Backert L, Schuster H, Werner JO, Klein R, Kohlbacher O, Kanz L, Salih HR, Rammensee HG, Stevanović S, Walz JS.

Oncoimmunology. 2018 Feb 14;7(4):e1316438. doi: 10.1080/2162402X.2017.1316438. eCollection 2018.

37.

The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy.

Neidert MC, Kowalewski DJ, Silginer M, Kapolou K, Backert L, Freudenmann LK, Peper JK, Marcu A, Wang SS, Walz JS, Wolpert F, Rammensee HG, Henschler R, Lamszus K, Westphal M, Roth P, Regli L, Stevanović S, Weller M, Eisele G.

Acta Neuropathol. 2018 Jun;135(6):923-938. doi: 10.1007/s00401-018-1836-9. Epub 2018 Mar 20.

PMID:
29557506
38.

Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity: A Randomized Clinical Trial.

Stahl A, Krohne TU, Eter N, Oberacher-Velten I, Guthoff R, Meltendorf S, Ehrt O, Aisenbrey S, Roider J, Gerding H, Jandeck C, Smith LEH, Walz JM; Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity (CARE-ROP) Study Group.

JAMA Pediatr. 2018 Mar 1;172(3):278-286. doi: 10.1001/jamapediatrics.2017.4838.

39.

Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells.

Maurer S, Kropp KN, Klein G, Steinle A, Haen SP, Walz JS, Hinterleitner C, Märklin M, Kopp HG, Salih HR.

Oncoimmunology. 2017 Nov 27;7(2):e1364827. doi: 10.1080/2162402X.2017.1364827. eCollection 2018.

40.

Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers.

Walz JS, Kowalewski DJ, Backert L, Nelde A, Kohlbacher O, Weide B, Kanz L, Salih HR, Rammensee HG, Stevanović S.

Leuk Lymphoma. 2018 Aug;59(8):1949-1958. doi: 10.1080/10428194.2017.1403022. Epub 2018 Jan 3.

PMID:
29295645
41.

Double-trap measurement of the proton magnetic moment at 0.3 parts per billion precision.

Schneider G, Mooser A, Bohman M, Schön N, Harrington J, Higuchi T, Nagahama H, Sellner S, Smorra C, Blaum K, Matsuda Y, Quint W, Walz J, Ulmer S.

Science. 2017 Nov 24;358(6366):1081-1084. doi: 10.1126/science.aan0207.

PMID:
29170238
42.

A Novel Approach to Managing Trans-Subclavian Transcatheter Aortic Valve Replacement With Regional Anesthesia.

Alexander B, Angaramo G, Walz JM, Kakouros N, Moiz Hafiz A, Walker J, Krapchev P.

J Cardiothorac Vasc Anesth. 2018 Jun;32(3):1391-1393. doi: 10.1053/j.jvca.2017.08.022. Epub 2017 Aug 15. No abstract available.

PMID:
29128481
43.

The immunopeptidomic landscape of ovarian carcinomas.

Schuster H, Peper JK, Bösmüller HC, Röhle K, Backert L, Bilich T, Ney B, Löffler MW, Kowalewski DJ, Trautwein N, Rabsteyn A, Engler T, Braun S, Haen SP, Walz JS, Schmid-Horch B, Brucker SY, Wallwiener D, Kohlbacher O, Fend F, Rammensee HG, Stevanović S, Staebler A, Wagner P.

Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):E9942-E9951. doi: 10.1073/pnas.1707658114. Epub 2017 Nov 1.

44.

A parts-per-billion measurement of the antiproton magnetic moment.

Smorra C, Sellner S, Borchert MJ, Harrington JA, Higuchi T, Nagahama H, Tanaka T, Mooser A, Schneider G, Bohman M, Blaum K, Matsuda Y, Ospelkaus C, Quint W, Walz J, Yamazaki Y, Ulmer S.

Nature. 2017 Oct 18;550(7676):371-374. doi: 10.1038/nature24048.

PMID:
29052625
45.

Should the Ramped Position Be "Sniffed at" in the ICU?

Scott JA, Walz JM, Heard SO.

Chest. 2017 Oct;152(4):693-694. doi: 10.1016/j.chest.2017.06.002. No abstract available.

PMID:
28991539
46.

The "PROMIS" of Magnetic Resonance Imaging Cost Effectiveness in Prostate Cancer Diagnosis?

Walz J.

Eur Urol. 2018 Jan;73(1):31-32. doi: 10.1016/j.eururo.2017.09.015. Epub 2017 Sep 29. No abstract available.

PMID:
28965689
47.

Thioether-stapled macrocyclic inhibitors of the EH domain of EHD1.

Kamens AJ, Mientkiewicz KM, Eisert RJ, Walz JA, Mace CR, Kritzer JA.

Bioorg Med Chem. 2018 Mar 15;26(6):1206-1211. doi: 10.1016/j.bmc.2017.09.007. Epub 2017 Sep 18.

48.

Fatty acid synthase as a potential therapeutic target in feline oral squamous cell carcinoma.

Walz JZ, Saha J, Arora A, Khammanivong A, O'Sullivan MG, Dickerson EB.

Vet Comp Oncol. 2018 Mar;16(1):E99-E108. doi: 10.1111/vco.12341. Epub 2017 Sep 4.

PMID:
28871635
49.

Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8+ cytotoxic T cells.

Heidenreich F, Rücker-Braun E, Walz JS, Eugster A, Kühn D, Dietz S, Nelde A, Tunger A, Wehner R, Link CS, Middeke JM, Stölzel F, Tonn T, Stevanovic S, Rammensee HG, Bonifacio E, Bachmann M, Zeis M, Ehninger G, Bornhäuser M, Schetelig J, Schmitz M.

Haematologica. 2017 Nov;102(11):e460-e464. doi: 10.3324/haematol.2017.167312. Epub 2017 Aug 24. No abstract available.

50.

The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk Analysis.

Tosco L, Laenen A, Briganti A, Gontero P, Karnes RJ, Bastian PJ, Chlosta P, Claessens F, Chun FK, Everaerts W, Gratzke C, Albersen M, Graefen M, Kneitz B, Marchioro G, Salas RS, Tombal B, Van den Broeck T, Van Der Poel H, Walz J, De Meerleer G, Bossi A, Haustermans K, Van Poppel H, Spahn M, Joniau S; European Multicenter Prostate Cancer Clinical and Translational Research group (EMPaCT).

Eur Urol Focus. 2018 Apr;4(3):369-375. doi: 10.1016/j.euf.2016.12.008. Epub 2017 Jan 17.

PMID:
28753838

Supplemental Content

Support Center